Consistent with this, the siRNA-based BRCA1 knockdown (BRCA1-KD) enhanced both basal and the H2O2-mediated ROS production in one normal-like (MCF10A) and two breast cancer (MCF7 and T47D) cell lines [77]. Here, BRCA1 is linked to breast carcinoma.